News

âš¡Bharat Biotech's Covaxin Efficacy Meets WHO Standards, Safe To Use, Says Joint Drugs Controller

By IANS

However, Reddy added that usually it is expected that the vaccines will give lifelong immunity. Citing the data involved in Covaxin approval, he said that the Phase 3 trials involved 24,000 subjects; and for Covishield, manufactured by the Serum Institute of India, the government has UK's Phase 3 efficacy data.

Read Full Story